Internal Medicine, Pulmonary Disease · San Diego, CA
NPI
1598955668
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 W Arbor Dr
San Diego, CA, 92103
Phone (800) 926-8273
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
255 services
Medicare patients, 2024
95
Average age 70
Drug cost, 2024
$8.5M
863 prescriptions
Company payments, 2025
$104
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Poch was code 99214 (office e&m - established), 81 times for 51 patients. In total David S Poch billed 255 services in 15 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 81 | 51 | $73.71 | $5,970 |
| 99233 Hospital E&M - Subsequent | Facility | 61 | 18 | $96.29 | $5,874 |
| 93451 Percutaneous Transcatheterization | Facility | 30 | 24 | $97.55 | $2,926 |
By year: 2022 $23K for 243 services; 2023 $21K for 224 services; 2024 $24K for 255 services.
Medicare prescription drug claims, 2024
In 2024, the drug David S Poch prescribed most often to Medicare patients was Opsumit (Macitentan), with 230 prescriptions and refills. In total David S Poch wrote 863 Medicare prescriptions that cost $8.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 230 | 230 | 22 | $2.9M |
| Tadalafil Generic | 126 | 130 | 13 | $159K |
| Uptravi Selexipag | 97 | 97 | Under 11 | $2.4M |
| Winrevair Sotatercept-Csrk | 71 | 71 | Under 11 | $1.3M |
| Veletri Epoprostenol Sodium | 56 | 56 | Under 11 | $54K |
| Ambrisentan Generic | 50 | 54 | Under 11 | $240K |
| Adempas Riociguat | 45 | 45 | Under 11 | $626K |
| Sildenafil Citrate Generic | 38 | 64 | Under 11 | $5,776 |
| Tyvaso Dpi Treprostinil | 34 | 34 | Under 11 | $793K |
| Furosemide Generic | 26 | 74 | Under 11 | $286 |
| Potassium Chloride Generic | 24 | 68 | Under 11 | $627 |
| Spironolactone Generic | 22 | 65 | Under 11 | $428 |
Brand drugs: 557 claims; generic drugs: 306 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Poch $104 ($104 in general payments such as food, travel and fees) from 2 companies. The largest payer was United Therapeutics Corporation with $104.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 4 | $104 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.